Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Phase II/III trial with IV Ampion in patients with COVID-19

Trial Profile

A Phase II/III trial with IV Ampion in patients with COVID-19

Status: Recruiting
Phase of Trial: Phase II/III

Latest Information Update: 06 Jan 2021

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs DMI 9523 (Primary)
  • Indications COVID 2019 infections
  • Focus Therapeutic Use
  • Sponsors Ampio Pharmaceuticals
  • Most Recent Events

    • 04 Jan 2021 According to an Ampio Pharmaceuticals media release, Status changed from planning to recruiting.
    • 17 Dec 2020 According to an Ampio Pharmaceuticals media release, clinical sites in Israel will be used concurrently with sites in the United States, as Israel has been recognized by the FDA to support the safety and efficacy of drugs in the United States.
    • 11 Sep 2020 New trial record
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top